Skip to content

Dr Katri Hämeen-Anttila

Affiliation:

Finnish Medicines Agency (FIMEA)                 

Country:

Finland

1. Current Status, Position

Dr Katri Hämeen-Anttila is currently the Head of Research and Development in the Finnish Medicines Agency (FIMEA), where she leads the research and development team. Research projects are conducted, by law, within the areas of pharmacoepidemiologic, pharmacoeconomic, and medicines policy research.

2. Education

Dr Hämeen-Anttila studied pharmacy at the University of Kuopio (currently University of Eastern Finland) and became a licensed pharmacist in 1999. In 2006 she obtained a PhD in social pharmacy at the University of Kuopio.

3. Research Area

Dr Hämeen-Anttila’s research focuses on patient perspective on medicine use, strategic development of medicines information, children’s medicine education, and medicine information needs of different patient groups, including patient counselling.

4. Conflict of interest: None


×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.